Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous (SC) Presentations
PHASE1
The main objective of this trial is to evaluate the pharmacokinetics (PK) o...
Managing Neovascular (Known as "Wet") Age-related Macular Degeneration Over 2 Years Using Different Treatment Schedules of 2 mg Intravitreal Aflibercept Injected in the Eye
PHASE4
This study aims to evaluate the optimal use, efficacy, and safety of a Trea...
A Prospective Randomized Double-Blinded Placebo Controlled, Explorative Phase I Trial to Investigate the Safety and Tolerability of Two Different Doses of Topically Administered APOSEC™ in Healthy Male Subjects With Artificial Dermal Wounds
PHASE1
This is a prospective, single center, randomized, double-blinded, placebo-c...
Status
Completed
Location
Medical University of Vienna, Department of Clinical Pharmacology
Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype
PHASE3
The purpose of this study is to evaluate if a 12-week total regimen of tela...